Abstract:Ethnopharmacological relevance: Catalpol is made from the root of Rehmannia glutinosa, a plant often used to treat a variety of diseases of the central nervous system in traditional Chinese medicine, such as Dementia, Apoplexy and Parkinson. According to the recent studies, catalpol can attenuate nerve damage by inhibiting neuroinflammation.Aim of the study: In this research, we examined catalopol's impact on neuroinflammation in LPS-induced BV2 cells, ulteriorly assessed the mechanism of the inflammasome.Materials and methods: BV2 cells were induced by LPS to build the neuroinflammatory model in vitro. The best time for LPS to induce the initial stage of neuroinflammation was screening by cell viability (CCK-8). Then the successful construction of the model were verified by cell morphology (optical microscope), and release of inflammatory factors (PCR).Further, catalpol was used for neuroinflammation intervention. The best intervention time of catalpol was screening by cell viability (CCK-8). BV2 cells were exposed to LPS and treated with catalpol (10μM, 100μM, 1000μM) for 24h. The better intervention concentration of catalpol against neuroinflammation was determined through cell viability (CCK-8), cell morphology (optical microscope), and release of inflammatory cytokines (IL-6) (PCR). Then the action of catalpol on LPS-induced BV2 cells polarization was evaluated by M1 (CD86) and M2 (CD206) phenotypic markers of BV2 polarization (WB, FCM). Finally, the mechanism of catalpol against neuroinflammation through NLRP3 inflammasome signal pathway was studied. The signal pathway of anti-inflammatory mechanism of catalpol was evaluated by the expression of NLRP3 inflammasome complex proteins (NLRP3、ASC and caspase-1) (WB、IF) and its upstream target (NF-κB) (WB), and its downriver effector inflammatory cytokines (IL-18、IL-1β) (PCR).Results: In contrast to the LPS group, the catalpol group's BV2 cell activity, length and number of cell branches, and production of IL-6 were all obviously attenusted. Moreover, the CD86 expression was enhanced by LPS and inhibited by catalpol, yet there was no discernible impact from CD206 expression. Further investigation revealed that the catalpol group's NF-κB、NLRP3、ASC、caspase-1、IL-18 and IL-1β expression were much lower than that of the model group.Conclusion: Catalpol has anti-inflammatory effect and inhibites the polarization of pro-inflammatory phenotype of microglia, but has no discernible impact on the polarization of anti-inflammatory phenotype. Catalpol attenuates neuroinflammation by preventing the NF-κB/NLRP3 inflammasome signaling path from becoming activated.

Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation

Analgesic Activity of Catalpol in Rodent Models of Neuropathic Pain, and Its Spinal Mechanism

VGLUT2/ Cdk5/p25 Signaling Pathway Contributed to Inflammatory Pain By CFA

Catalpol Inhibits LPS-Induced Neuroinflammation and Alleviates the Activation of NLRP3 Inflammasome in Microglia

The Analgesia Effect of Aucubin on CFA-Induced Inflammatory Pain by Inhibiting Glial Cells Activation-Mediated Inflammatory Response via Activating Mitophagy

Pra-C Exerts Analgesic Effect Through Inhibiting Microglial Activation in Anterior Cingulate Cortex in Complete Freund's Adjuvant-Induced Mouse Model.

Catalpol Ameliorates Sodium Taurocholate-Induced Acute Pancreatitis In Rats Via Inhibiting Activation Of Nuclear Factor Kappa B

Catalpol Attenuates IL-1β Induced Matrix Catabolism, Apoptosis and Inflammation in Rat Chondrocytes and Inhibits Cartilage Degeneration.

The related mechanism of complete Freund's adjuvant-induced chronic inflammation pain based on metabolomics analysis

Catalpol ameliorates LPS-induced inflammatory response by activating AMPK/mTOR signaling pathway in rat intestinal epithelial cells

Trifluoro-Icaritin Ameliorates Neuroinflammation Against Complete Freund's Adjuvant-Induced Microglial Activation by Improving CB2 Receptor-Mediated IL-10/β-endorphin Signaling in the Spinal Cord of Rats

Catalpol reduced LPS induced BV2 immunoreactivity through NF-κB/NLRP3 pathways: an in Vitro and in silico study

Paeonol ameliorates CFA-induced inflammatory pain by inhibiting HMGB1/TLR4/NF-κB p65 pathway

Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways

Paeoniflorin Attenuates Inflammatory Pain by Inhibiting Microglial Activation and Akt-NF-κB Signaling in the Central Nervous System

Catalpol inhibits LPS plus IFN-γ-induced inflammatory response in astrocytes primary cultures.

Catalpol Ameliorates High-Fat Diet-Induced Insulin Resistance and Adipose Tissue Inflammation by Suppressing the JNK and NF-κB Pathways.

Catalpol Alleviates Ang II-Induced Renal Injury Through NF‐κB Pathway and TGF-β1/Smads Pathway

Cyclo(L-Pro-L-Trp) from Chilobrachys jingzhao alleviates formalin-induced inflammatory pain by suppressing the inflammatory response and inhibiting TRAF6-mediated MAPK and NF-κB signaling pathways

Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation

Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2/FAK/Src signaling pathway